Approval · Notice of Compliance 27586 · 2022
AZILECT: Notice of Compliance 27586
Issued February 14, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27586
- Date
- February 14, 2022
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the Product Monograph to the 2020 PM template and to update the bottle labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZILECT | Not yet assigned | — |
Medicinal ingredients
- RASAGILINE MESYLATE 0.5 MG per TAB
- RASAGILINE MESYLATE 1 MG per TAB